
Albert Mark Navarro
Examiner (ID: 439, Phone: (571)272-0861 , Office: P/1645 )
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1645, 1621, 2899, 1817 |
| Total Applications | 2079 |
| Issued Applications | 1540 |
| Pending Applications | 155 |
| Abandoned Applications | 410 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16832361
[patent_doc_number] => 11008602
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-05-18
[patent_title] => Non-replicative transduction particles and transduction particle-based reporter systems
[patent_app_type] => utility
[patent_app_number] => 16/222611
[patent_app_country] => US
[patent_app_date] => 2018-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10774
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 155
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16222611
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/222611 | Non-replicative transduction particles and transduction particle-based reporter systems | Dec 16, 2018 | Issued |
Array
(
[id] => 16549947
[patent_doc_number] => 10883096
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-01-05
[patent_title] => Carrier for targeting nerve cells
[patent_app_type] => utility
[patent_app_number] => 16/220662
[patent_app_country] => US
[patent_app_date] => 2018-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7256
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16220662
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/220662 | Carrier for targeting nerve cells | Dec 13, 2018 | Issued |
Array
(
[id] => 14156573
[patent_doc_number] => 20190105389
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-11
[patent_title] => ADJUVANT SYSTEM FOR ORAL VACCINE ADMINISTRATION
[patent_app_type] => utility
[patent_app_number] => 16/212088
[patent_app_country] => US
[patent_app_date] => 2018-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11936
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16212088
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/212088 | ADJUVANT SYSTEM FOR ORAL VACCINE ADMINISTRATION | Dec 5, 2018 | Abandoned |
Array
(
[id] => 14497987
[patent_doc_number] => 20190192648
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-27
[patent_title] => COMPOSITIONS COMPRISING STREPTOCOCCUS PNEUMONIAE POLYSACCHARIDE-PROTEIN CONJUGATES AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/208778
[patent_app_country] => US
[patent_app_date] => 2018-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 62262
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16208778
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/208778 | Compositions comprising | Dec 3, 2018 | Issued |
Array
(
[id] => 17330084
[patent_doc_number] => 11220537
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-01-11
[patent_title] => Antibodies against
[patent_app_type] => utility
[patent_app_number] => 16/204624
[patent_app_country] => US
[patent_app_date] => 2018-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 25
[patent_no_of_words] => 37258
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 538
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16204624
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/204624 | Antibodies against | Nov 28, 2018 | Issued |
Array
(
[id] => 17602912
[patent_doc_number] => 11331381
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-17
[patent_title] => Vaccine compositions for use against digital dermatitis in a mammal
[patent_app_type] => utility
[patent_app_number] => 16/764762
[patent_app_country] => US
[patent_app_date] => 2018-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 11
[patent_no_of_words] => 17419
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16764762
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/764762 | Vaccine compositions for use against digital dermatitis in a mammal | Nov 15, 2018 | Issued |
Array
(
[id] => 15191285
[patent_doc_number] => 10493113
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-12-03
[patent_title] => Compositions and methods for treating disease using a
[patent_app_type] => utility
[patent_app_number] => 16/190735
[patent_app_country] => US
[patent_app_date] => 2018-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 42263
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16190735
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/190735 | Compositions and methods for treating disease using a | Nov 13, 2018 | Issued |
Array
(
[id] => 14310189
[patent_doc_number] => 20190144798
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-16
[patent_title] => CLEANING COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 16/188651
[patent_app_country] => US
[patent_app_date] => 2018-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14519
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 221
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16188651
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/188651 | Cleaning composition | Nov 12, 2018 | Issued |
Array
(
[id] => 16284048
[patent_doc_number] => 20200277650
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-03
[patent_title] => POLYNUCLEOTIDE-BINDING PROTEIN FOR USE IN DIAGNOSIS
[patent_app_type] => utility
[patent_app_number] => 15/733101
[patent_app_country] => US
[patent_app_date] => 2018-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12990
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15733101
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/733101 | POLYNUCLEOTIDE-BINDING PROTEIN FOR USE IN DIAGNOSIS | Nov 12, 2018 | Abandoned |
Array
(
[id] => 18233414
[patent_doc_number] => 11597963
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-03-07
[patent_title] => Microbial selection system
[patent_app_type] => utility
[patent_app_number] => 16/762733
[patent_app_country] => US
[patent_app_date] => 2018-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 7118
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 145
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16762733
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/762733 | Microbial selection system | Nov 8, 2018 | Issued |
Array
(
[id] => 18172004
[patent_doc_number] => 11571698
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-07
[patent_title] => Bacterial test plate having antibacterial agent introduced thereinto, and transparent plate
[patent_app_type] => utility
[patent_app_number] => 16/769841
[patent_app_country] => US
[patent_app_date] => 2018-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 22
[patent_no_of_words] => 5384
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16769841
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/769841 | Bacterial test plate having antibacterial agent introduced thereinto, and transparent plate | Nov 1, 2018 | Issued |
Array
(
[id] => 17392507
[patent_doc_number] => 11241495
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-02-08
[patent_title] => Immunogenic composition
[patent_app_type] => utility
[patent_app_number] => 16/179476
[patent_app_country] => US
[patent_app_date] => 2018-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 13324
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 147
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16179476
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/179476 | Immunogenic composition | Nov 1, 2018 | Issued |
Array
(
[id] => 13986509
[patent_doc_number] => 20190062412
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-28
[patent_title] => GM HYBRIDOMA CELL, MONOCLONAL ANTIBODY, KIT AND PREPARATION METHOD AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/172175
[patent_app_country] => US
[patent_app_date] => 2018-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9387
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16172175
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/172175 | GM hybridoma cell, monoclonal antibody, kit and preparation method and use thereof | Oct 25, 2018 | Issued |
Array
(
[id] => 13929059
[patent_doc_number] => 20190048045
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-14
[patent_title] => ACTINOBACILLUS PLEUROPNEUMONIAE RECOMBINANT TOXIN PROTEIN AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/171802
[patent_app_country] => US
[patent_app_date] => 2018-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7958
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16171802
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/171802 | ACTINOBACILLUS PLEUROPNEUMONIAE RECOMBINANT TOXIN PROTEIN AND APPLICATION THEREOF | Oct 25, 2018 | Abandoned |
Array
(
[id] => 16901089
[patent_doc_number] => 20210180005
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-17
[patent_title] => MICROORGANISM LYOPHILIZED COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 16/758947
[patent_app_country] => US
[patent_app_date] => 2018-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9165
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16758947
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/758947 | Microorganism lyophilized composition | Oct 22, 2018 | Issued |
Array
(
[id] => 13931831
[patent_doc_number] => 20190049431
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-14
[patent_title] => METHOD OF PREPARING CELLS EXHIBITING DRUG RESISTANCE, METHOD OF SCREENING ANTICANCER DRUGS, AND ANTICANCER DRUG SCREENING KIT
[patent_app_type] => utility
[patent_app_number] => 16/164914
[patent_app_country] => US
[patent_app_date] => 2018-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11814
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16164914
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/164914 | Method of preparing cells exhibiting drug resistance, method of screening anticancer drugs, and anticancer drug screening kit | Oct 18, 2018 | Issued |
Array
(
[id] => 15606579
[patent_doc_number] => 10584339
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-10
[patent_title] => Tumor associated vaccines and compositions for disrupting tumor-derived immunosuppression for use in combination cancer immunotherapy
[patent_app_type] => utility
[patent_app_number] => 16/160554
[patent_app_country] => US
[patent_app_date] => 2018-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 53
[patent_figures_cnt] => 88
[patent_no_of_words] => 32418
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16160554
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/160554 | Tumor associated vaccines and compositions for disrupting tumor-derived immunosuppression for use in combination cancer immunotherapy | Oct 14, 2018 | Issued |
Array
(
[id] => 18101241
[patent_doc_number] => 11541110
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-03
[patent_title] => Comprehensive vaccine design for commensal disease progression
[patent_app_type] => utility
[patent_app_number] => 16/755537
[patent_app_country] => US
[patent_app_date] => 2018-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 35
[patent_no_of_words] => 17062
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16755537
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/755537 | Comprehensive vaccine design for commensal disease progression | Oct 11, 2018 | Issued |
Array
(
[id] => 14497981
[patent_doc_number] => 20190192645
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-27
[patent_title] => PERIODONTITIS VACCINE AND RELATED COMPOSITIONS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 16/158155
[patent_app_country] => US
[patent_app_date] => 2018-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10012
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -49
[patent_words_short_claim] => 129
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16158155
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/158155 | Periodontitis vaccine and related compositions and methods of use | Oct 10, 2018 | Issued |
Array
(
[id] => 16493541
[patent_doc_number] => 10859575
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-08
[patent_title] => None
[patent_app_type] => utility
[patent_app_number] => 16/154054
[patent_app_country] => US
[patent_app_date] => 2018-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 17360
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16154054
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/154054 | None | Oct 7, 2018 | Issued |